Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma

Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma

In transplant-eligible patients who undergo upfront autologous stem cell transplant (ASCT) for multiple myeloma (MM), standard practice is to treat with six to eight cycles of induction therapy followed by high-dose chemotherapy with ASCT. A gap between the end of induction and the day of ASCT exist...

Full description

Bibliographic Details
Main Authors: Alicia Bao, Qiuhong Zhao, Ruchi Kudalkar, Jose Rodriguez, Nidhi Sharma, Naresh Bumma, Srinivas S. Devarakonda, Abdullah M. Khan, Elvira Umyarova, Ashley E. Rosko, Don Benson, Francesca Cottini
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Oncology
Subjects:
myeloma
stem cell transplant (SCT)
outcome
immune profiling
disease progression
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1216461/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1216461/full

Similar Items